1078 related articles for article (PubMed ID: 17312209)
21. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
[TBL] [Abstract][Full Text] [Related]
22. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
Whalley DG; Maurer WG; Knapik AL; Estafanous FG
Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
[TBL] [Abstract][Full Text] [Related]
23. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
24. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
25. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
[TBL] [Abstract][Full Text] [Related]
26. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
[TBL] [Abstract][Full Text] [Related]
27. High concentration sevoflurane induction of anesthesia accelerates onset of vecuronium neuromuscular blockade.
Yamaguchi S; Egawa H; Okuda K; Mishio M; Okuda Y; Kitajima T
Can J Anaesth; 2001 Jan; 48(1):34-7. PubMed ID: 11212046
[TBL] [Abstract][Full Text] [Related]
28. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
Cammu G; Coart D; De Graeve K; Beelen R
Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
[TBL] [Abstract][Full Text] [Related]
29. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
30. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
31. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
[TBL] [Abstract][Full Text] [Related]
32. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia.
Kim KS; Cheong MA; Lee HJ; Lee JM
Anesth Analg; 2004 Oct; 99(4):1080-1085. PubMed ID: 15385354
[TBL] [Abstract][Full Text] [Related]
33. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
[TBL] [Abstract][Full Text] [Related]
34. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
[TBL] [Abstract][Full Text] [Related]
35. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
36. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time.
Motamed C; Donati F
Can J Anaesth; 2002 Nov; 49(9):907-12. PubMed ID: 12419714
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
38. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
39. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
[TBL] [Abstract][Full Text] [Related]
40. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
